81 related articles for article (PubMed ID: 8767437)
1. [Effect of elevated head position in bed in therapy of gastroesophageal reflux].
Pollmann H; Zillessen E; Pohl J; Rosemeyer D; Abucar A; Armbrecht U; Bornhofen B; Herz R
Z Gastroenterol; 1996 Jun; 34 Suppl 2():93-9. PubMed ID: 8767437
[TBL] [Abstract][Full Text] [Related]
2. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
3. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
4. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
Sontag SJ; O'Connell S; Khandelwal S; Greenlee H; Schnell T; Nemchausky B; Chejfec G; Miller T; Seidel J; Sonnenberg A
Am J Gastroenterol; 2003 May; 98(5):987-99. PubMed ID: 12809818
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
[TBL] [Abstract][Full Text] [Related]
7. [Maintenance therapy in reflux esophagitis].
Katsoulis S; Fölsch UR
Z Gastroenterol; 1997 Feb; 35(2):159-61. PubMed ID: 9163230
[No Abstract] [Full Text] [Related]
8. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
[TBL] [Abstract][Full Text] [Related]
11. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
12. Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.
Tepes B; Stabuc B; Kocijancic B; Ivanusa M
Hepatogastroenterology; 2009; 56(89):67-74. PubMed ID: 19453031
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients.
Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061
[TBL] [Abstract][Full Text] [Related]
14. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management?
Ellis KK; Oehlke M; Helfand M; Lieberman D
Am J Gastroenterol; 1997 Sep; 92(9):1472-4. PubMed ID: 9317065
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of reflux esophagitis].
Berges W; Wienbeck M
Z Gastroenterol; 1993 Nov; 31 Suppl 5():15-7. PubMed ID: 7910994
[No Abstract] [Full Text] [Related]
18. Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Jansen EH; Tuynman HA; Schrijver M; Dieleman LA; Meuwissen SG
Am J Gastroenterol; 1997 Nov; 92(11):1997-2000. PubMed ID: 9362179
[TBL] [Abstract][Full Text] [Related]
19. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
20. [Anti-reflux surgery in patients with adequate response to proton pump inhibitors - is there an indication?].
Horstmann R; Gregor N; Classen C; Röttgermann S; Palmes D
Z Gastroenterol; 2006 Dec; 44(12):1217-22. PubMed ID: 17163371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
